---
title: "Optimi Health Corp. (OPTH.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OPTH.US.md"
symbol: "OPTH.US"
name: "Optimi Health Corp."
datetime: "2026-05-21T13:31:14.609Z"
locales:
  - [en](https://longbridge.com/en/quote/OPTH.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OPTH.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OPTH.US.md)
---

# Optimi Health Corp. (OPTH.US)

## Company Overview

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.

| Item | Detail |
|------|--------|
| Exchange | US Market |
| Website | [www.optimihealth.ca](https://www.optimihealth.ca) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/OPTH.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/OPTH.US/norm.md)
- [Related News](https://longbridge.com/en/quote/OPTH.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/OPTH.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**